1,297
Views
27
CrossRef citations to date
0
Altmetric
Review Article

Diagnosis of asthma – new theories

, MD
Pages 538-544 | Received 21 Jun 2014, Accepted 22 Nov 2014, Published online: 07 Jan 2015

References

  • GINA (Global Initiative for asthma). Global Strategy for Asthma Management and Prevention (update 2010). Available from: wwwginasthmaorg. 2010. [last accessed 1 July 2013]
  • Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma – summary report 2007. J Allergy Clin Immunol 2007;120:S94–S138
  • British guideline on the management of asthma. Thorax 2008;63:iv1–iv121
  • Holgate ST, Robinson C, Church MK, Howarth PH. The release and role of inflammatory mediators in asthma. Clin Immunol Rev 1985;4:241–288
  • Robinson C, Holgate ST. Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. Clin Sci (Lond) 1985;68:103–112
  • Holgate ST, Kay AB. Mast cells, mediators and asthma. Clin Allergy 1985;15:221–234
  • Holgate ST. Inflammatory cells and their mediators in the pathogenesis of asthma. Postgrad Med J 1988;64:82–95
  • International Consensus Report on Diagnosis and Treatment of Asthma. Clin Exp Allergy 1992;22(s1):1–72
  • Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991;88:425–534
  • Holgate ST, Howarth PH, Beasly R, Agius R, Church MK. Cellular and biochemical events in the pathogenesis of asthma. Eur J Respir Dis Suppl 1986;144:34–76
  • Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806–817
  • Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001;8:35A–40A
  • Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142–149
  • de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, Carrozzi L, et al. The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003;58:221–228
  • Pearson M, Barnes N, Thomas M, Tate H, Simnett S. Evaluating the effectiveness of asthma treatment in real-life practice. J Eval Clin Pract 2004;10:297–305
  • Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST, et al. Worldwide severity and control of asthma in children and adults:the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40–47
  • Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 2005;42:529–535
  • FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 2006;13:253–259
  • Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007;120:1360–1367
  • Laforest L, Van Ganse E, Devouassoux G, Osman LM, Brice K, Massol J, Bauguil G, et al. Asthmatic patients’ poor awareness of inadequate disease control: a pharmacy-based survey. Ann Allergy Asthma Immunol 2007;98:146–152
  • McIvor RA, Boulet LP, FitzGerald JM, Zimmerman S, Chapman KR. Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician 2007;53:673–677, 672
  • Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT):findings from a national Web-based survey. J Allergy Clin Immunol 2007;119:1454–1461
  • Chapman KR. Asthma in Canada: missing the treatment targets. CMAJ 2008;178:1027–1028
  • Holgate S, Bisgaard H, Bjermer L, Haahtela T, Haughney J, Horne R, McIvor A, et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008;32:1433–1442
  • Braido F, Baiardini I, Stagi E, Piroddi MG, Balestracci S, Canonica GW. Unsatisfactory asthma control: astonishing evidence from general practitioners and respiratory medicine specialists. J Investig Allergol Clin Immunol 2010;20:9–12
  • de Benedictis FM, Carloni I, Bush A. The dark side of the moon: severe therapy-resistant asthma in children. Monaldi Arch Chest Dis 2012;77:83–93
  • Cypcar D, Busse WW. Steroid-resistant asthma. J Allergy Clin Immunol 1993;92:362–372
  • Nimmagadda SR, Spahn JD, Leung DY, Szefler SJ. Steroid-resistant asthma: evaluation and management. Ann Allergy Asthma Immunol 1996;77:345–355. quiz 55–6
  • Leung DY, Szefler SJ. New insights into steroid resistant asthma. Pediatr Allergy Immunol 1998;9:3–12
  • Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001–1008
  • The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003;22:470–477
  • Wenzel S. Severe asthma: epidemiology, pathophysiology and treatment. The Mt Sinai J Med 2003;70:185–190
  • Adcock IM, Ito K. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 2004;4:257–262
  • Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004;1:264–268
  • Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005;172:149–160
  • Wenzel SE. Factors determining the severity of asthma. Clin Exp Allergy 1998;28:119–125
  • Wenzel S. Mechanisms of severe asthma. Clin Exp Allergy 2003;33:1622–1628
  • Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113:101–108
  • ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. “Refractory” eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004;170:601–605
  • Wenzel S. Physiologic and pathologic abnormalities in severe asthma. Clin Chest Med 2006;27:29–40
  • Romagnoli M, Caramori G, Braccioni F, Ravenna F, Barreiro E, Siafakas NM, Vignola AM, et al. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy 2007;37:552–557
  • Wenzel SE, Busse WW. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:14–21. quiz 2–3
  • Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF. Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 2008;8:171–178
  • Reddy RC. Severe asthma: approach and management. Postgrad Med J 2008;84:115–120. quiz 9
  • Bush A, Saglani S. Management of severe asthma in children. Lancet 2010;376:814–825
  • Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER, et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010;125:1028–1036.e13
  • Hedlin G, Bush A, Lodrup Carlsen K, Wennergren G, De Benedictis FM, Melen E, Paton J, et al. Problematic severe asthma in children, not one problem but many: a GA2LEN initiative. Eur Respir J 2010;36:196–201
  • Balzar S, Fajt ML, Comhair SA, Erzurum SC, Bleecker E, Busse WW, Castro M, et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am J Respir Crit Care Med 2011;183:299–309
  • Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, Wagener AH, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011;66:910–917
  • Fitzpatrick AM, Teague WG, Meyers DA, Peters SP, Li X, Li H, Wenzel SE, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011;127:382–389.e1
  • Gibeon D, Chung KF. The investigation of severe asthma to define phenotypes. Clin Exp Allergy 2012;42:678–692
  • Kupczyk M, Wenzel S. US and European severe asthma cohorts: what can they teach us about severe asthma? J Intern Med 2012;272:121–132
  • Poon AH, Eidelman DH, Martin JG, Laprise C, Hamid Q. Pathogenesis of severe asthma. Clin Exp Allergy 2012;42:625–637
  • Shah R, Saltoun CA. Chapter 14: Acute severe asthma (status asthmaticus). Allergy Asthma Proc 2012;33:47–50
  • Yim RP, Koumbourlis AC. Steroid-resistant asthma. Paediatr Respir Rev 2012;13:172–177
  • Marklund B, Tunsater A, Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam Pract 1999;16:112–116
  • Burdon J. Is it asthma? Aust Fam Physician 2001;30:988
  • Aaron SD, Vandemheen KL, Boulet LP, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008;179:1121–1131
  • McGrath KW, Fahy JV. Negative methacholine challenge tests in subjects who report physician-diagnosed asthma. Clin Exp Allergy 2011;41:46–51
  • Löwhagen O. Diagnosis of asthma – a new approach. Allergy 2012;67:713–717
  • British Guideline on the Management of Asthma. A national clinical guideline. British Thoracic Society; 2009
  • Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 2002;121:1051–1057
  • Nowobilski R, Plaszewski M, Wloch T, Mika P, Gajewski P, Brozek JL. Physiotherapy in asthma – seeking consensus. J Asthma 2013;50:681–686
  • Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176:231–237
  • Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010;138:18S–24S
  • Sterk P. Airway hyperresponsiveness. Lecture, ERS, Vienna; 2009
  • Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and field exercise challenge in elite cross-country skiers. Br J Sports Med 2010;44:827–832
  • Balder B, Lindholm NB, Lowhagen O, Palmqvist M, Plaschke P, Tunsater A, Toren K, et al. Predictors of self-assessed work ability among subjects with recent-onset asthma. Respir Med 1998;92:729–734
  • Weiler JM, Bonini S, Coifman R, Craig T, Delgado L, Capao-Filipe M, Passali D, et al. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol 2007;119:1349–1358
  • Lowhagen O. Methodological aspects of assessment of non-specific bronchial hyperreactivity. Eur J Respir Dis Suppl 1984;136:33–40
  • Löwhagen O, Balder B. Histamine- and methacholine tests in cases of bronchial reactivity – ten years’ experience. Läkartidningen 1990;87:3413–34138
  • Millqvist E, Bende M, Lowhagen O. Sensory hyperreactivity – a possible mechanism underlying cough and asthma-like symptoms. Allergy 1998;53:1208–1212
  • Millqvist E. The airway sensory hyperreactivity syndrome. Pulm Pharmacol Ther 2011;24:263–266
  • Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med 2008;14:39–45
  • Fitch KD, Sue-Chu M, Anderson SD, Boulet LP, Hancox RJ, McKenzie DC, Backer V, et al. Asthma and the elite athlete: summary of the International Olympic Committee’s consensus conference, Lausanne, Switzerland, January 22–24, 2008. J Allergy Clin Immunol 2008;122:254–260.e7
  • Weiler JM, Anderson SD, Randolph C, Bonini S, Craig TJ, Pearlman DS, Rundell KW, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105:S1–S47
  • Pongdee T, Li JT. Exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol 2013;110:311–315
  • Leuppi JD. Bronchoprovocation tests in asthma: direct versus indirect challenges. Curr Opin Pulm Med 2014;20:31–36
  • Gibson PG, Simpson JL, Ryan NM, Vertigan AE. Mechanisms of cough. Curr Opin Allergy Clin Immunol 2014;14:55–61
  • Romberg KA, Berggren AC, Bjermer L. Asthma control in patients on fixed dose combination evaluated with mannitol challenge test. Respir Med 2014;108:264–270
  • Lowhagen O, Arvidsson M, Bjarneman P, Jorgensen N. Exercise-induced respiratory symptoms are not always asthma. Respir Med 1999;93:734–738
  • Hammo AH, Weinberger MM. Exercise-induced hyperventilation: a pseudoasthma syndrome. Ann Allergy Asthma Immunol 1999;82:574–578
  • Weinberger M. Exercise induced dyspnoea: if not asthma, then what? Arch Dis Child 2006;91:543–544
  • Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007;120:855–864
  • Anderson SD. Exercise-induced bronchoconstriction in the 21st century. J Am Osteopath Assoc 2011;111:S3–S10
  • Undem BJ, Nassenstein C. Airway nerves and dyspnea associated with inflammatory airway disease. Respir Physiol Neurobiol 2009;167:36–44
  • Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999;14:951–957
  • Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E, Toren K, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res 2009;10:94
  • Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Responsiveness to three bronchial provocation tests in patients with asthma. Chest 2003;124:2171–2177
  • Toren K, Ekerljung L, Kim JL, Hillstrom J, Wennergren G, Ronmark E, Lotvall J, et al. Adult-onset asthma in west Sweden – incidence, sex differences and impact of occupational exposures. Respir Med 2011;105:1622–1628
  • Bosley CM, Corden ZM, Cochrane GM. Psychosocial factors and asthma. Respir Med 1996;90:453–457
  • Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Coughing during mannitol challenge is associated with asthma. Chest 2004;125:1985–1992
  • Widdicombe J. Airway receptors. Respir Physiol 2001;125:3–15
  • Undem BJ, Carr MJ. The role of nerves in asthma. Curr Allergy Asthma Rep 2002;2:159–165
  • Nishino T. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth 2011;106:463–474
  • Hopp RJ, Bewtra AK, Nair NM, Townley RG. Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984;74:154–158
  • Chan-Yeung M. Spirometry and tests of bronchial hyperresponsiveness in population studies. Int J Tuberc Lung Dis 2000;4:633–638
  • Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ 2001;322:1098–1100
  • Hagman C, Janson C, Emtner M. Breathing retraining – a five-year follow-up of patients with dysfunctional breathing. Respir Med 2011;105:1153–1159
  • Folgering H. The pathophysiology of hyperventilation syndrome. Monaldi Arch Chest Dis 1999;54:365–372
  • Ringsberg KC, Akerlind I. Presence of hyperventilation in patients with asthma-like symptoms but negative asthma test responses: provocation with voluntary hyperventilation and mental stress. J Allergy Clin Immunol 1999;103:601–608
  • Salome CM, Peat JK, Britton WJ, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy 1987;17:271–281
  • Bai J, Peat J, Berry G, Marks G, Woolcock A. Questionnaire items that predict asthma and other respiratory conditions in adults. Chest 1998;114:1343–1348
  • Ringsberg KC, Bjarneman P, Lowhagen O, Oden A, Toren K. Differences in trigger factors and symptoms between patients with asthma-like symptoms and patients with asthma: development of a basis for a questionnaire. Respir Med 2002;96:305–311
  • Thomas M, McKinley RK, Freeman E, Foy C, Price D. The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J 2005;14:78–82
  • Johansson A, Millqvist E, Nordin S, Bende M. Relationship between self-reported odor intolerance and sensitivity to inhaled capsaicin: proposed definition of airway sensory hyperreactivity and estimation of its prevalence. Chest 2006;129:1623–1628
  • Laurino RA, Barnabe V, Saraiva-Romanholo BM, Stelmach R, Cukier A, Nunes Mdo P. Respiratory rehabilitation: a physiotherapy approach to the control of asthma symptoms and anxiety. Clinics (Sao Paulo, Brazil) 2012;67:1291–1297
  • Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001;163:924–929
  • Manning HL, Schwartzstein RM. Respiratory sensations in asthma: physiological and clinical implications. J Asthma 2001;38:447–460
  • Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J 2005;25:380–385
  • Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T, Takishima T, et al. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991;71:2183–2190
  • Manning HL, Mahler DA. Pathophysiology of dyspnea. Monaldi Arch Chest Dis 2001;56:325–330
  • Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22:1026–1041
  • Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry: interpretation and practical applications. Chest 2014;146:841–847
  • Rosenfeld M, Allen J, Arets BH, Aurora P, Beydon N, Calogero C, Castile RG, et al. An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. Ann Am Thorac Soc 2013;10:S1–S11
  • Baxter MA, Coates D, Wilson AM. Airways resistance in bronchial challenge testing. J Asthma 2015;52:34–39

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.